Unexpectedly, p300 also dramatically enhanced SUMO1/Ubc9-induced or endogenous PEPCK1 sumoylation (Fig. 4a,b), thereby suppressing endogenous PEPCK1 expression levels in different liver cancer cells (Fig. 4b). The gene discussed is SUMO1; the disease is liver cancer.